TY  - GEN
AU  - Hoff,Paulo M
AU  - Hochhaus,Andreas
AU  - Pestalozzi,Bernhard C
AU  - Tebbutt,Niall C
AU  - Li,Jin
AU  - Kim,Tae Won
AU  - Koynov,Krassimir D
AU  - Kurteva,Galina
AU  - Pintér,Tamás
AU  - Cheng,Ying
AU  - van Eyll,Brigitte
AU  - Pike,Laura
AU  - Fielding,Anitra
AU  - Robertson,Jane D
AU  - Saunders,Mark P
TI  - Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II)
SN  - 1527-7755
PY  - 2012///1219
KW  - Administration, Oral
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Brazil
KW  - Capecitabine
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Deoxycytidine
KW  - analogs & derivatives
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Infusions, Intravenous
KW  - Kaplan-Meier Estimate
KW  - Leucovorin
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Organoplatinum Compounds
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Pyridines
KW  - Quinazolines
KW  - Survival Analysis
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2012.42.6031
ER  -